A first pregnancy seems associated with a positive effect on the course of inflammatory bowel disease: data from a prospective pregnancy cohort

Abstract Objectives: The effect of pregnaSSncy on the course of inflammatory bowel disease (IBD) remains controversial. We aimed to describe the disease course before and after a first pregnancy in IBD patients. Methods: We analyzed data from a prospectively followed-up pregnancy cohort (minimal follow-up of 7 years), with clinical, biochemical and endoscopic characteristics obtained pre-pregnancy, during pregnancy and post-pregnancy. Possible factors associated with relapse (disease activity during pregnancy, maternal age, smoking, alcohol use, pre-pregnancy BMI, mode of delivery, thiopurine use during pregnancy, biological use during pregnancy, combination of thiopurine and biological use during pregnancy, breastfeeding, IBD diagnosis, endoscopic scores) were scored. Results: One hundred twenty six patients (95 Crohn’s Disease [CD; 75%] and 31 Ulcerative Colitis/IBD unclassified [UC/IBD-U; 25%]) were enrolled, with one hundred pregnancies occurring in 100 primigravida patients. All pregnancies resulted in live birth. Twenty patients (20%) had a relapse during pregnancy. The median number of relapses/patient/year was 0.25 (IQR 0.5) and 0 (IQR 0.43) respectively before and after pregnancy (p = .00). For CD patients the median relapses/person/year was 0.25 (IQR 0.5) before and 0 (IQR 0.25) after delivery (p = .00), for UC/IBD-U patients there was no significant difference. In the post-partum period more UC patients relapsed compared to CD patients (68% vs 30.7%, p = .01). Seven-year IBD-course was unchanged in the 26 women who did not become pregnant. Conclusion: In this prospective observational cohort study, we found a lower rate of relapses in the 4 years after delivery compared to the 3 years prior to a first pregnancy. Post-partum, more UC patients experienced a relapse compared to CD patients.

[1]  B. Koslowsky,et al.  Factors Associated with Inflammatory Bowel Disease Flare During Pregnancy Among Women with Preconception Remission , 2020, Digestive Diseases and Sciences.

[2]  O. Koren,et al.  Modulation of cytokine patterns and microbiome during pregnancy in IBD , 2019, Gut.

[3]  C. J. van der Woude,et al.  Modulatory Effects of Pregnancy on Inflammatory Bowel Disease , 2019, Clinical and translational gastroenterology.

[4]  M. Peppelenbosch,et al.  A Direct Effect of Sex Hormones on Epithelial Barrier Function in Inflammatory Bowel Disease Models , 2019, Cells.

[5]  C. J. van der Woude,et al.  Preconception Care Reduces Relapse of Inflammatory Bowel Disease During Pregnancy. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  A. Bitton,et al.  The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. , 2016, Gastroenterology.

[7]  C. J. van der Woude,et al.  Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety , 2015, Gut.

[8]  C. J. van der Woude,et al.  The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. , 2015, Journal of Crohn's & colitis.

[9]  F. Granath,et al.  Birth Outcomes in Women with Inflammatory Bowel Disease: Effects of Disease Activity and Drug Exposure , 2014, Inflammatory bowel diseases.

[10]  J. Gisbert,et al.  The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO‐EpiCom Study of 209 pregnant women , 2013, Alimentary pharmacology & therapeutics.

[11]  A. Kornbluth,et al.  Relapses of Inflammatory Bowel Disease During Pregnancy: In-Hospital Management and Birth Outcomes , 2008, The American Journal of Gastroenterology.

[12]  C. O'Morain,et al.  Does Pregnancy Change the Disease Course? A Study in a European Cohort of Patients with Inflammatory Bowel Disease , 2006, The American Journal of Gastroenterology.

[13]  S. Pignata,et al.  Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. , 1996, The Italian journal of gastroenterology.